-
FROM TOKYO TO WASHINGTON: IMPACT OF JAPAN’S HTA ENVIRONMENT ON U.S. MFN PRICING AND LAUNCH STRATEGY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ABIRATERONE, APALUTAMIDE, ENZALUTAMIDE, AND DOCETAXEL DOUBLETS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A REAL-WORLD EVIDENCE ANALYSIS
Mar 18, 2026, 21:38 PM -
COMPARISON OF GUIDELINE-RECOMMENDED AND PRELIMINARY RISK-BASED APPROACHES TO SELECTION OF LUNG CANCER PATIENTS FOR LYMPH NODE STAGING
Mar 18, 2026, 21:38 PM -
COMPARISON OF 5-YEAR SURVIVAL AND ESTIMATED LIFE YEARS BETWEEN TWO DATA CUTS OF STUDY 309/KEYNOTE-775
Mar 18, 2026, 21:38 PM -
EVALUATING PATIENT REPORTING HABITS IN CLINICAL TRIALS: A COMPARISON OF EVENT-DRIVEN VS. PROMPTED EVENING EDIARY ENTRIES
Mar 18, 2026, 21:38 PM -
REAL-TIME AND SHORT RECALL OF FLARES IN PNH, CAPTURED THROUGH LONGITUDINAL HOME-REPORTED OUTCOMES
Mar 18, 2026, 21:38 PM -
AN EFFECTIVE METHODOLOGICAL FRAMEWORK FOR EXECUTING MULTINATIONAL, PATIENT-CENTRED CROSS-SECTIONAL SURVEYS IN RARE DISEASES: FACILITATING EVIDENCE GENERATION WITH GENERALISABILITY ACROSS CONDITIONS TO SUPPORT COMMERCIAL VIABILITY
Mar 18, 2026, 21:38 PM -
THE COST OF PERFORMING FEES: ESTIMATING ANNUALIZED COSTS OF MOBILE FEES PROVIDERS FOR LTACH AND SNFS
Mar 18, 2026, 21:38 PM -
SOCIAL DETERMINANTS OF HEALTH AND GLP-1 PRESCRIBING PATTERNS IN T2D AND OBESITY: REAL-WORLD EVIDENCE FROM A LARGE, NATIONAL U.S. LINKED EHR-CLAIMS NETWORK
Mar 18, 2026, 21:38 PM -
PREVALENCE OF DEPRESSION AMONG ADULTS WITH SICKLE CELL DISEASE IN TEXAS MEDICAID
Mar 18, 2026, 21:38 PM -
REAL-WORLD EPIDEMIOLOGY, CLINICAL OUTCOMES AND PATIENT SATISFACTION AMONG USERS OF ARTIFICIAL PANCREAS SYSTEMS IN TYPE 1 AND TYPE 2 DIABETES INSIGHTS FROM PHYSICIAN NOTES USING NLP
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF OCTOCOG ALFA VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS IN CENTRAL AMERICA, ECUADOR AND PERÚ
Mar 18, 2026, 21:38 PM -
EVOLUTION OF PATIENT-REPORTED BURDEN AND UNMET NEEDS IN HEREDITARY ANGIOEDEMA: A COMPARATIVE SOCIAL MEDIA LISTENING ANALYSIS
Mar 18, 2026, 21:38 PM -
USER EVALUATION OF AN AGENTIC AI ASSISTANT FOR REAL-WORLD EVIDENCE FEASIBILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
DOES SUBSTANDARD CANCER CARE ADVERSELY IMPACT PATIENT FINANCIAL WELL BEING? AN ANALYSIS OF CANCER REGISTRY, CLAIMS, AND CREDIT REPORT SCORES
Mar 18, 2026, 21:38 PM -
STRUCTURED EXPERT ELICITATION IN GLOBAL HTAS: ACCEPTANCE AND APPLICATION
Mar 18, 2026, 21:38 PM -
PREDICTING OVERALL SURVIVAL FROM SURROGATE ENDPOINTS: A TWO-STAGE BAYESIAN META-ANALYTIC SURROGACY FRAMEWORK INCORPORATING RECOVERED INDIVIDUAL-LEVEL DEPENDENCE INFORMATION
Mar 18, 2026, 21:38 PM -
AUTOMATED PERITONEAL DIALYSIS (APD) VS HEMODIALYSIS (HD) IN CHINA: COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF TRIFLURIDINE/TIPIRACIL PLUS BEVACIZUMAB VERSUS REGORAFENIB IN REFRACTORY METASTATIC COLORECTAL CANCER IN KAZAKHSTAN
Mar 18, 2026, 21:38 PM -
ENHANCING REAL-WORLD DATA COMPLETENESS IN TYPE 2 DIABETES THROUGH LINKAGE OF CLAIMS, EMR, AND LABORATORY DATA
Mar 18, 2026, 21:38 PM
